Publications by authors named "Pablo Labarga"

Claim this Profile
H
High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.
Pablo Barreiro, Pablo Labarga, Carmen de Mendoza, Laura Benítez-Gutiérrez, José V Fernandez-Montero

Antivir Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antiretroviral therapy for HIV infection.
Vicente Soriano, Jose Vicente Fernandez-Montero, Laura Benitez-Gutierrez, Carmen de Mendoza, Ana Arias, Pablo Labarga

Expert Opin Drug Saf· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug interactions in HIV-infected patients treated for hepatitis C.
Vicente Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez

Expert Opin Drug Metab Toxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C cure with antiviral therapy--benefits beyond the liver.
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito

Antivir Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Protease Inhibitors Associated with Increased HCV Viral Load in Coinfected Patients.
Pablo Labarga

AIDS Rev· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New hepatitis C therapies for special patient populations.
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito

Expert Opin Pharmacother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and management of treatment failure to new oral hepatitis C drugs.
Laura Benítez-Gutiérrez, Pablo Barreiro, Pablo Labarga, Carmen de Mendoza, José V Fernandez-Montero

Expert Opin Pharmacother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner.
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, Pablo Barreiro

Liver Int· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
Isabella Esposito, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza

Expert Opin Drug Saf· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.
Pablo Labarga, Jose V Fernandez-Montero, Carmen de Mendoza, Pablo Barreiro, Javier Pinilla

Antivir Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New update of the DHHS guidelines for adults and children.
Pablo Labarga

AIDS Rev· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C.
Pablo Labarga, José V Fernández-Montero, Carmen de Mendoza, Pablo Barreiro, Vincent Soriano

Antivir Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.
Pablo Barreiro, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Laura Benítez-Gutiérrez

J Clin Virol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.
Pablo Labarga, Jose V Fernández-Montero, Mariola López, Pablo Barreiro, Carmen de Mendoza

Antivir Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging challenges in managing hepatitis B in HIV patients.
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José M Peña, José V Fernández-Montero

Curr HIV/AIDS Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misconceptions about HIV infection in Kinshasa (Democratic Republic of Congo): a case-control study on knowledge, attitudes and practices.
Silvia Carlos, Miguel Ángel Martínez-González, Eduardo Burgueño, Cristina López-Del Burgo, Miguel Ruíz-Canela, Pablo Labarga

Sex Transm Infect· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
News on antiretroviral therapy.
Pablo Labarga

AIDS Rev· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug interactions with new hepatitis C oral drugs.
Vincent Soriano, Pablo Labarga, Pablo Barreiro, José V Fernandez-Montero, Carmen de Mendoza

Expert Opin Drug Metab Toxicol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New promises for hepatitis C cure in HIV coinfection.
Pablo Labarga

AIDS Rev· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.
Vincent Soriano, Eugenia Vispo, Rocío Sierra-Enguita, Carmen de Mendoza, José V Fernández-Montero, Pablo Labarga

AIDS· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and treatment of chronic hepatitis B in HIV-positive patients.
Vincent Soriano, Carmen de Mendoza, José V Fernández-Montero, Pablo Labarga, Pablo Barreiro

Ann Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of antiretroviral therapy.
Pablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, Pablo Labarga, Vincent Soriano

Expert Opin Drug Metab Toxicol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
José Vicente Fernández-Montero, Eugenia Vispo, Pablo Barreiro, Rocío Sierra-Enguita, Carmen de Mendoza, Pablo Labarga

Clin Infect Dis· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.
Eugenia Vispo, Pablo Barreiro, Zulema Plaza, Jose Vicente Fernández-Montero, Pablo Labarga

AIDS· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir, abacavir and lamivudine as HIV therapy.
Jose Vicente Fernandez-Montero, Pablo Barreiro, Pablo Labarga, Carmen De Mendoza, Vicente Soriano

Expert Opin Pharmacother· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis